Ibrexafungerp: A Novel Oral Glucan Synthase Inhibitor
M R Davis, M A Donnelley, G R ThompsonMedical Mycology
July 2019
Larkin L, Long L, Isham N, Borroto-Esoda K, Barat S, Angulo D, Ghannoum M
Antimicrobial Agents and Chemotherapy
March 2019
Wring S, Borroto-Esoda K, Solon E, Angulo D
Antimicrobial Agents and Chemotherapy
January 2019
Wring S, Murphy G, Atiee G, Corr C, Hyman M, Willett M, Angulo D.
Clinical Pharmacology in Drug Development
June 2018
Wring S, Murphy G, Atiee G, Corr C, Hyman M, Willett M, Angulo D.
Journal of Clinical Pharmacology
May 2018
Schell WA, Jones AM, Borroto-Esoda K, Alexander B
Antimicrobial Agents and Chemotherapy
November 2017
Jimenez-Ortigosa C, Perez WB, Angulo D, Borroto-Esoda K, Perlin DS
Antimicrobial Agents and Chemotherapy
September 2017
Pfaller MA, Messer SA, Rhomberg PR, Borroto-Esoda K, Castanheira M
Antimicrobial Agents and Chemotherapy
August 2017
Berkow EL, Angulo D, Lockhart SR
Antimicrobial Agents and Chemotherapy
July 2017
Marcos-Zambrano LJ, Gomez-Perosanz M, Escribano P, Bouza E, Guinea
Journal of Antimicrobial Chemotherapy
July 2017